Quantbot Technologies LP Boosts Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Quantbot Technologies LP grew its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 77.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 114,318 shares of the company’s stock after purchasing an additional 49,742 shares during the quarter. Quantbot Technologies LP owned approximately 0.06% of Cellebrite DI worth $1,925,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. FMR LLC raised its stake in Cellebrite DI by 136.3% during the 3rd quarter. FMR LLC now owns 5,616,757 shares of the company’s stock worth $94,586,000 after acquiring an additional 3,239,307 shares in the last quarter. Telemark Asset Management LLC acquired a new stake in shares of Cellebrite DI during the third quarter worth about $6,736,000. Advisors Asset Management Inc. lifted its holdings in shares of Cellebrite DI by 130.5% in the 3rd quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company’s stock valued at $52,000 after purchasing an additional 1,742 shares during the last quarter. Empowered Funds LLC acquired a new stake in shares of Cellebrite DI in the 3rd quarter valued at about $2,002,000. Finally, MQS Management LLC purchased a new position in Cellebrite DI during the 3rd quarter worth approximately $294,000. Hedge funds and other institutional investors own 45.88% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Lake Street Capital increased their price objective on Cellebrite DI from $13.50 to $17.00 and gave the company a “buy” rating in a report on Friday, August 16th. Bank of America lifted their price objective on shares of Cellebrite DI from $13.00 to $17.00 and gave the company a “buy” rating in a research note on Friday, August 16th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Cellebrite DI from $15.00 to $18.00 and gave the stock a “buy” rating in a research note on Friday, August 16th. Craig Hallum boosted their price target on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Finally, JPMorgan Chase & Co. increased their price objective on Cellebrite DI from $21.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, November 7th. Eight investment analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of “Buy” and an average price target of $20.29.

Cellebrite DI Trading Down 0.2 %

Shares of CLBT opened at $19.89 on Friday. The firm has a market capitalization of $4.10 billion, a PE ratio of -12.83, a P/E/G ratio of 2.72 and a beta of 1.50. The stock’s 50 day moving average is $18.17 and its two-hundred day moving average is $15.07. Cellebrite DI Ltd. has a twelve month low of $7.91 and a twelve month high of $21.00.

Cellebrite DI (NASDAQ:CLBT) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.14 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.05. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The firm had revenue of $106.90 million for the quarter, compared to analyst estimates of $102.06 million. During the same quarter in the prior year, the company posted $0.09 earnings per share. Cellebrite DI’s quarterly revenue was up 27.0% on a year-over-year basis. On average, sell-side analysts predict that Cellebrite DI Ltd. will post 0.32 EPS for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.